Literature DB >> 9224775

In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.

M R Rashidi1, J A Smith, S E Clarke, C Beedham.   

Abstract

Famciclovir, a 9-substituted guanine derivative, is a new antiviral agent which undergoes rapid hydrolysis and oxidation in man to yield the active antiherpes agent, penciclovir. Studies with human liver cytosol have indicated that the oxidation of the penultimate metabolite, 6-deoxypenciclovir, to penciclovir is catalyzed by the molybdenum hydroxylase, aldehyde oxidase. In the present study the oxidation of famciclovir and 6-deoxypenciclovir with partially purified molybdenum hydroxylases from human, guinea pig, rabbit, and rat livers and bovine milk xanthine oxidase has been investigated. Famciclovir and 6-deoxypenciclovir were oxidized predominantly to 6-oxo-famciclovir and penciclovir, respectively, by human, guinea pig, and rat liver aldehyde oxidase. Small amounts of 8-oxo and 6,8-dioxo-metabolites were also formed from each substrate. Famciclovir and 6-deoxypenciclovir were good substrates for rabbit liver aldehyde oxidase but, in each case, two major metabolites were formed. 6-Deoxypenciclovir was converted to penciclovir and 8-oxo-6-deoxypenciclovir in approximately equal quantities; famciclovir was oxidized to 6-oxo-famciclovir and a second metabolite which, on the basis of chromatographic and UV spectral data, was thought to be 8-oxo-famciclovir. Two groups of Sprague Dawley rats were identified; those containing hepatic aldehyde oxidase and xanthine oxidase and those with only xanthine oxidase. These have been designated AO-active and AO-inactive rats, respectively. Famciclovir was not oxidized by enzyme from AO-inactive rats or bovine milk xanthine oxidase although 6-deoxypenciclovir was slowly converted to penciclovir by rat liver or milk xanthine oxidase. Inhibitor studies showed in human, guinea pig, and rabbit liver that xanthine oxidase did not contribute to the oxidation of famciclovir and 6-deoxypenciclovir; thus it is proposed that drug activation in vivo would be catalyzed solely by aldehyde oxidase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224775

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  28 in total

1.  Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions.

Authors:  John T Barr; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2011-09-22       Impact factor: 3.922

2.  A new multi-wavelength model-based method for determination of enzyme kinetic parameters.

Authors:  Mohammad-Hossein Sorouraddin; Kaveh Amini; Abdolhossein Naseri; Javad Vallipour; Jalal Hanaee; Mohammad-Reza Rashidi
Journal:  J Biosci       Date:  2010-09       Impact factor: 1.826

3.  The impact of single nucleotide polymorphisms on human aldehyde oxidase.

Authors:  Tobias Hartmann; Mineko Terao; Enrico Garattini; Christian Teutloff; Joshua F Alfaro; Jeffrey P Jones; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2012-01-25       Impact factor: 3.922

4.  Monitoring in vivo metabolism and elimination of the endogenous DNA adduct, M1dG {3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)-one}, by accelerator mass spectrometry.

Authors:  Charles G Knutson; Paul L Skipper; Rosa G Liberman; Steven R Tannenbaum; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

Review 5.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

6.  Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.

Authors:  Kanika V Choughule; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Biochem Pharmacol       Date:  2015-05-29       Impact factor: 5.858

7.  Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.

Authors:  J M Loutsch; B Sainz; M E Marquart; X Zheng; P Kesavan; S Higaki; J M Hill; R Tal-Singer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 8.  Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.

Authors:  Enrico Garattini; Ralf Mendel; Maria João Romão; Richard Wright; Mineko Terao
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

9.  Isolation of liver aldehyde oxidase containing fractions from different animals and determination of kinetic parameters for benzaldehyde.

Authors:  R S Kadam; K R Iyer
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

10.  Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase.

Authors:  Catarina Coelho; Alessandro Foti; Tobias Hartmann; Teresa Santos-Silva; Silke Leimkühler; Maria João Romão
Journal:  Nat Chem Biol       Date:  2015-08-31       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.